PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: PD0332991|DRUG: Anastrozole|DRUG: Goserelin|PROCEDURE: Surgery (standard of care)|PROCEDURE: Tumor biopsy
Sponsor: Washington University School of Medicine
Collaborators: Pfizer